Make Better Decisions - Finding and Evaluating Generic and Branded Drug Market Entry Opportunities

Get the Book: Make Better Decisions

Finding and Evaluating Generic and Branded Drug Market Entry Opportunities

PDF eBook: Just $10 Get Print Book on Amazon

Serving hundreds of leading biopharmaceutical companies globally:

Julphar
McKinsey
McKesson
Citi
Covington
Mallinckrodt

Generated: August 25, 2019

DrugPatentWatch Database Preview

Patent: 9,623,041

  Try a free trial


See Plans and Pricing

« Back to Dashboard

Summary for Patent: 9,623,041
Title:Polymalic acid-based nanobiopolymer compositions
Abstract: Nanobiopolymeric conjugates based on biodegradable, non-toxic and non-immunogenic poly (.beta.-L-malic acid) PMLA covalently linked to molecular modules that include morpholino antisense oligonucleotides (AONa), an siRNA or an antibody specific for an oncogenic protein in a cancer cell, and an antibody specific for a transferrin receptor protein, are provided. Methods for treating a cancer in subject with nanobiopolymeric conjugates are described.
Inventor(s): Inoue; Satoshi (Beverly Hills, CA), Ding; Hui (Los Angeles, CA), Holler; Eggehard (Los Angeles, CA), Black; Keith L. (Los Angeles, CA), Ljubimova; Julia Y. (Studio City, CA)
Assignee: CEDARS-SINAI MEDICAL CENTER (Los Angeles, CA)
Application Number:13/930,533
Patent Claims:see list of patent claims

Details for Patent 9,623,041

Applicant Tradename Biologic Ingredient Dosage Form BLA Number Approval Date Patent No. Assignee Estimated Patent Expiration Status Orphan Source
Genentech HERCEPTIN trastuzumab VIAL; INTRAVENOUS 103792 001 1998-09-25   Try a Free Trial CEDARS-SINAI MEDICAL CENTER (Los Angeles, CA) 2030-12-30 RX Orphan search
>Applicant >Tradename >Biologic Ingredient >Dosage Form >BLA >Number >Approval Date >Patent No. >Assignee >Estimated Patent Expiration >Status >Orphan >Source

Subscribe to access the full database, or try a Free Trial

Make Better Decisions: Try a trial or see plans & pricing

Serving hundreds of leading biopharmaceutical companies globally:

Citi
Medtronic
US Army
Julphar
US Department of Justice
Colorcon

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.